![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Leukemia |
Free Subscription
1 Am J Hematol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Leukemia is free of charge.
Caution in using second generation tyrosine kinase inhibitor, especially for
first line therapy of chronic myeloid leukemia.
Am J Hematol. 2022 May 23. doi: 10.1002/ajh.26618.
PubMed
Risk of MDS/AML with the addition of neoadjuvant carboplatin to standard
chemotherapy for triple negative breast cancer.
Ann Oncol. 2022 Mar 14. pii: S0923-7534(22)00364.
PubMed
The Impact of T cell Immunity on Chemotherapy Response in Childhood Acute
Lymphoblastic Leukemia.
Blood. 2022 Jun 8. pii: 485490. doi: 10.1182/blood.2021014495.
PubMed
Abstract available
Role of Allogeneic Transplantation In Chronic Myelomonocytic Leukemia: An
International Collaborative Analysis.
Blood. 2022 Jun 6. pii: 485477. doi: 10.1182/blood.2021015173.
PubMed
Abstract available
A CAPTIVATE-ing new regimen for CLL.
Blood. 2022;139:3229-3230.
PubMed
High BMP4 expression in low/intermediate risk BCP-ALL identifies children with
poor outcomes.
Blood. 2022;139:3303-3313.
PubMed
Abstract available
Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary
analysis of the CAPTIVATE FD cohort.
Blood. 2022;139:3278-3289.
PubMed
Abstract available
CD147-specific chimeric antigen receptor T cells effectively inhibit T cell acute
lymphoblastic leukemia.
Cancer Lett. 2022;542:215762.
PubMed
Abstract available
Phosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric
Inhibitors in FLT3-ITD-Driven AML.
Cancer Res. 2022;82:2141-2155.
PubMed
Abstract available
Bosutinib-induced lung injury: a report of two cases and literature review.
Int J Hematol. 2022;115:902-905.
PubMed
Abstract available
Unrelated cord blood transplantation for adult-onset EBV-associated T-cell and
NK-cell lymphoproliferative disorders.
Int J Hematol. 2022;115:873-881.
PubMed
Abstract available
T cell clonal expansion and STAT3 mutations: a characteristic feature of acquired
chronic T cell-mediated pure red cell aplasia.
Int J Hematol. 2022;115:816-825.
PubMed
Abstract available
Erythroblast predominance without CD41/cyCD41-positive blasts predicts favorable
prognosis in patients with myelodysplastic syndromes and acute myeloid leukemias
treated with azacitidine.
Int J Hematol. 2022;115:852-859.
PubMed
Abstract available
Trends in Grade 5 Toxicity and Response in Phase I Trials in Hematologic
Malignancy: 20-Year Experience From the Cancer Therapy Evaluation Program at the
National Cancer Institute.
J Clin Oncol. 2022;40:1949-1957.
PubMed
Abstract available
The Clinical Landscape of NRAS-mutated Juvenile Myelomonocytic Leukemia-like
Myeloproliferation Includes Children With Costello Syndrome.
J Pediatr Hematol Oncol. 2022 Jun 3. pii: 00043426-990000000-00041.
PubMed
Abstract available
Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation Rescues Marrow
Failure From Acute Leukemia Therapy in a Patient With Previously Undiagnosed
Ligase IV Syndrome.
J Pediatr Hematol Oncol. 2022 Jun 1. pii: 00043426-990000000-00040.
PubMed
Abstract available
Central nervous system involvement in adult acute myeloid leukemia patients.
Leuk Res. 2022;118:106882.
PubMed
Novel mitochondria-targeting compounds selectively kill human leukemia cells.
Leukemia. 2022 Jun 7. pii: 10.1038/s41375-022-01614.
PubMed
Abstract available
Relapsed acute myeloid leukemia in children and adolescents: current treatment
options and future strategies.
Leukemia. 2022 Jun 6. pii: 10.1038/s41375-022-01619.
PubMed
Abstract available
Evolution of eligibility criteria for non-transplant randomized controlled trials
in adults with acute myeloid leukemia.
Leukemia. 2022 Jun 3. pii: 10.1038/s41375-022-01624.
PubMed
Abstract available
Maintenance therapy for acute lymphoblastic leukemia: basic science and clinical
translations.
Leukemia. 2022 Jun 2. pii: 10.1038/s41375-022-01591.
PubMed
Abstract available
Evidence supporting that the attribution of first success in use of arsenic for
the treatment of leukaemia should be to David Lissauer (1836-1892).
Leukemia. 2022;36:1697-1698.
PubMed
Recommendations for the management of COVID-19 in patients with haematological
malignancies or haematopoietic cell transplantation, from the 2021 European
Conference on Infections in Leukaemia (ECIL 9).
Leukemia. 2022;36:1467-1480.
PubMed
Abstract available
Development of [(211)At]astatine-based anti-CD123 radioimmunotherapy for acute
leukemias and other CD123+ malignancies.
Leukemia. 2022;36:1485-1491.
PubMed
Abstract available
CD99 as a novel therapeutic target on leukemic progenitor cells in FLT3-ITD(mut)
AML.
Leukemia. 2022;36:1685-1688.
PubMed
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by